Winrevair Gains Approval For Pulmonary Arterial Hypertension, But High Price Could Limit Uptake 0 02.04.2024 10:47 Forbes.com Newly approved Winrevair has shown important benefits to PAH patients. Its high price and correspondingly limited cost-effectiveness could, however, restrain its uptake. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
